A Randomized, Open-Labelled, active controlled, prospective clinical study to evaluate the Anti-Diabetic activity of a Standardized Ayurvedic Herbal Formulation (CTE Capsule) as compared to Standard Oral Hypoglycemic Therapy (with Metformin and Vildagliptin) in Newly Diagnosed type-2 Diabetic Patients. - NI

Maharashtra University of health sciences Nashik0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1. Newly diagnosed T2DM with any symptom of Polyuria, Polydipsia, Polyphagia,
•Bodyache, Giddiness, Polyneuritis, Fatigue,
•Matted hair / entangled hair,
•Sweet taste in mouth,
•Numbness of Hands & Legs,
•Burning sensation of hands & legs,
•Dryness of mouth,
•Dryness of palate,
•Dryness of throat,
•Polydipsia,
•Increased bodily wastes,
•Stickiness/excessive excreta at body orifices,
•Burning sensation of body,
•Numbness of body parts,
•Tingling sensation,
•Urine afflicted with symptoms as in urinary diseases,
•Foul smell of body,
•Always feeling sleepy,
•Always feeling drowsy,
•2. HbA1c 6.5 to 8.5
•3. BMI More than 23 Upto 40
•4. Not taking any OHA
•5. Subjects of either sex, 18-60 years
•6. Subjects who agree to participate in the study and submit a written informed consent

•1.Known Cases of type I DM
•2. Patients of gestational diabetes
•3. Any unstable Heart disease
•4. Pregnant / Lactating women.
•5. Alcoholics and/or drug abusers
•6. Patients with evidence of malignancy
•7. Patients suffering from major systemic illness necessitating long term drug treatment
•(Rheumatoid arthritis, Psycho-Neuro, endocrinal disorders, etc.)
•8. Patients who have completed participation in any other clinical trial during the past
•one (01) month.
•9. Any other condition which the Investigator thinks may jeopardize the study.

发起方

Maharashtra University of health sciences Nashik